The current price-to-earnings ratio of AVNS can't be determined, as the TTM EPS of -$1.33 is negative. Avanos Medical's last PE ratio on record was 30.66 in March 2023.
The mean historical PE ratio of Avanos Medical over the last ten years is 74.44. In the past ten years, AVNS's PE ratio was at its highest in the Mar 2015 quarter at 307.5, with a price of $49.2 and an EPS of $0.16. The Sep 2022 quarter recorded the bottom point at 22.69, with a price of $21.78 and an EPS of $0.96.
Maximum annual increase: 34.32% in 2018
Maximum annual decrease: -90.6% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | 25.06 | -90.6% |
| 2021 | 266.69 | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | 36.71 | 34.32% |
| 2017 | 27.33 | -37.19% |
| 2016 | 43.51 | N/A |
| 2015 | N/A | N/A |
| 2014 | 78.4 | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| STE STERIS plc | 36.69 | $20.7B |
| SYK Stryker Corp | 36.78 | $124B |
| AVNS Avanos Medical Inc | N/A | $905.68M |
The current price to earnings ratio of AVNS can't be calculated, as its EPS of -$1.33 is negative.
The average PE ratio for AVNS stock over the past 3 years is 85.36.
The average PE ratio for AVNS stock over the past 5 years is 89.59.
The highest quarterly PE ratio in the last ten years has been 307.5 and it was in the Mar 2015 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.